S K AGE Exports — Ketoconazole Exporter Profile
Indian Pharmaceutical Exporter · #12 for Ketoconazole · $453.5K export value · DGFT Verified
S K AGE Exports is the #12 Indian exporter of Ketoconazole with $453.5K in export value and 50 verified shipments. S K AGE Exports holds a 1.1% market share in Ketoconazole exports across 10 countries. The company exports 9 pharmaceutical products worth $25.0M across 5 therapeutic categories.
S K AGE Exports — Ketoconazole Export Profile: Buyers & Destinations
Where Does S K AGE Exports Export Ketoconazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $121.3K | 8 | 19.8% |
| MYANMAR | $108.6K | 6 | 17.7% |
| TANZANIA | $98.0K | 8 | 16.0% |
| UGANDA | $72.1K | 11 | 11.8% |
| SIERRA LEONE | $60.5K | 5 | 9.9% |
| ANGOLA | $36.4K | 4 | 5.9% |
| NETHERLANDS ANTILLES | $35.4K | 8 | 5.8% |
| MOZAMBIQUE | $28.4K | 4 | 4.6% |
| SIERRA LEONA | $24.7K | 1 | 4.0% |
| NETHERLAND | $6.7K | 1 | 1.1% |
S K AGE Exports exports Ketoconazole to 15 countries. The largest destination is PHILIPPINES accounting for 19.8% of S K AGE Exports's Ketoconazole shipments, followed by MYANMAR (17.7%) and TANZANIA (16.0%). These destinations reflect S K AGE Exports's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ketoconazole from S K AGE Exports?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | SIERRA LEONA | $520.7K | 55 |
| ERRA | NETHERLANDS | $32.1K | 3 |
S K AGE Exports supplies Ketoconazole to 2 buyers globally. The largest buyer is TO THE ORDER (SIERRA LEONA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ketoconazole Export Value and How Much Does S K AGE Exports Contribute?
India exported $22.2M worth of Ketoconazole through 4,053 shipments from 446 suppliers to 139 countries, serving 944 buyers globally. S K AGE Exports contributes $453.5K to this total, accounting for 1.1% of India's Ketoconazole exports. S K AGE Exports ships Ketoconazole to 15 countries through 2 buyers.
What Is the Average Shipment Value for S K AGE Exports's Ketoconazole Exports?
S K AGE Exports's average Ketoconazole shipment value is $9.1K per consignment, based on 50 shipments totaling $453.5K. The largest destination is PHILIPPINES (19.8% of S K AGE Exports's Ketoconazole exports).
How Does S K AGE Exports Compare to Other Indian Ketoconazole Exporters?
S K AGE Exports ranks #12 among 446 Indian Ketoconazole exporters with a 1.1% market share. The top 3 exporters are KUSUM HEALTHCARE PRIVATE LIMITED ($6.8M), ENCUBE ETHICALS PRIVATE LIMITED ($5.8M), STRIDES PHARMA SCIENCE LIMITED ($1.4M). S K AGE Exports processed 50 shipments to 10 destination countries.
What Ketoconazole Formulations Does S K AGE Exports Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| KETOCONAZOLE CREAM 2% W/W (KETOZ) UNIT:3 | $72.6K | 6 |
| KETOCONAZOLE CREAM 2% W/W (NIZOCHEM) UNI | $56.0K | 3 |
| KETOCONAZOLE CREAM 2% W/W KETOZ UNIT:30 GM | $44.7K | 5 |
| KETOCONAZOLE, CLOBETASOL PROPIONATE AND | $38.6K | 2 |
| HARMLESS MEDICINE - KETOCONAZOLE CREAM2% W/W (KETOZ) Unit : 30 gm | $32.5K | 2 |
| HARMLESS MEDICINE - KETOCONAZOLE CREAM 2% W/W (KETOZ) Unit : 30 gm | $31.2K | 2 |
| HARMLESS MEDICINE- KETOCONAZOLE CREAM 2%W/W (KETOZ) UNIT : 30 GM | $29.2K | 1 |
| KETOCONAZOLE CREAM 2% W/W KETSOKANT UNIT:15 GM | $26.0K | 1 |
| HARMLESS MEDICINE-KETOCONAZOLE CREAM 2%W/W (RETACONAZOLE) UNIT : 15 GMNOS | $25.9K | 3 |
| KETOCONAZOLE CREAM 2% W/WKETOZ UNIT:30GM | $24.7K | 1 |
S K AGE Exports exports 39 distinct Ketoconazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is KETOCONAZOLE CREAM 2% W/W (KETOZ) UNIT:3 with 6 shipments worth $72.6K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does S K AGE Exports Compare to Nearest Ketoconazole Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | CLAROID PHARMACEUTICALS PRIVATE LIMITED | $747.5K | 19 | 1 | $39.3K |
| 8 | TRIOPLUS PHARMACEUTICALS PRIVATE LIMITED | $600.0K | 12 | 2 | $50.0K |
| 12 | S K AGE EXPORTS ★ | $453.5K | 50 | 10 | $9.1K |
| 13 | GRACURE PHARMACEUTICALS LIMITED | $423.8K | 42 | 4 | $10.1K |
| 14 | KESAR PHARMA PRIVATE LIMITED | $420.3K | 21 | 2 | $20.0K |
S K AGE Exports ranks #12 among 446 Indian Ketoconazole exporters. Average shipment value of $9.1K compared to the market average of $49.7K. The closest competitors by value are CLAROID PHARMACEUTICALS PRIVATE LIMITED and TRIOPLUS PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Ketoconazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 523 | 12.9% |
| SAHAR AIR | 463 | 11.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 388 | 9.6% |
| JNPT/ NHAVA SHEVA SEA | 253 | 6.2% |
| DELHI AIR | 229 | 5.7% |
| JNPT | 217 | 5.4% |
| DELHI AIR CARGO ACC (INDEL4) | 201 | 5.0% |
| Bombay Air | 130 | 3.2% |
What Other Antifungals Products Does S K AGE Exports Export?
S K AGE Exports also exports these antifungals products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on S K AGE Exports's Ketoconazole Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like S K AGE Exports. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased shipping costs and extended transit times. These disruptions have resulted in freight inflation, with transport charges doubling and surcharges ranging from $4,000 to $8,000 per shipment. (pharmaceuticalcommerce.com) Such logistical challenges can impact the timely delivery of pharmaceuticals, particularly to markets in the Middle East and North Africa.
Conversely, US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. India supplies 47% of the US's generic drugs, underscoring its critical role in the American healthcare system. (orfonline.org) However, the imposition of tariffs on Indian pharmaceutical products by the US poses a risk, potentially leading to reduced export volumes and increased compliance costs. (transdatanexus.com)
In the European Union, the implementation of the Falsified Medicines Directive (FMD) necessitates stringent compliance measures. Indian exporters must ensure adherence to these regulations to maintain market access. The India–EFTA Trade and Economic Partnership Agreement, effective from October 1, 2025, aims to eliminate or reduce tariffs on goods traded between India and EFTA countries, potentially enhancing market opportunities for exporters like S K AGE Exports. (en.wikipedia.org)
S K AGE Exports — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with 752 FDA-approved, 2,050 WHO GMP-certified, and 286 EDQM-approved manufacturing facilities as of 2024. (ibef.org) Instances of non-compliance have decreased, indicating improved adherence to quality standards. For S K AGE Exports, maintaining such compliance is essential to ensure uninterrupted market access and to uphold the company's reputation in the global pharmaceutical industry.
About S K AGE Exports
S K AGE Exports exports 9 products worth $25.0M. Beyond Ketoconazole, top products include Artemether, Clotrimazole, Gentamicin, Erythromycin, Sulfadoxine. View the complete S K AGE Exports profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ketoconazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ketoconazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: S K AGE Exports matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 62 individual customs records matching S K AGE Exports exporting Ketoconazole, covering 39 formulations to 15 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 139+ countries, 944+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ketoconazole Export Data from S K AGE Exports
Access shipment-level details, pricing data, buyer connections, and competitive analysis for S K AGE Exports's Ketoconazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
S K AGE Exports
Full Company Profile →
9 products · $25.0M total trade · 5 categories
Ketoconazole Stats
Company Overview
Top Products by S K AGE Exports
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for S K AGE Exports.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ketoconazole. For current shipment-level data, contact TransData Nexus.